Suchergebnisse - "Vanella, Vito"

PubPharm (6)

1

The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era

enthalten in: Current oncology reports | 2019

von Vanella, V. | Festino, L. | Trojaniello, C. | +4

2

Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutations

enthalten in: Expert review of clinical pharmacology | 2019

von Trojaniello, C. | Festino, L. | Vanella, V. | +1

ErratumIn: Expert Rev Clin Pharmacol. 2021 Jan;14(1):i. - PMID 32501733

3

Combination Treatment of Patients with BRAF-Mutant Melanoma : A New Standard of Care

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2017

von Simeone, E. | Grimaldi, A. | Festino, L. | +3

4

Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma : a case series

enthalten in: British journal of cancer | 2016

von Carlino, M. | Vanella, V. | Girgis, C. | +7

5

Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase : a case report from a phase III trial

enthalten in: Cancer immunology, immunotherapy : CII | 2016

von Ascierto, P. | Vanella, V. | Grimaldi, A. | +4

6

Novel mechanisms and therapeutic approaches in melanoma : targeting the MAPK pathway

enthalten in: Discovery medicine | 2015

von Grimaldi, A. | Simeone, E. | Festino, L. | +3

1
[1]